China's SAMR to strengthen antitrust enforcement to ensure supplies of drugs in shortage
MLex Summary: China’s State Administration for Market Regulation will continue to enhance antitrust enforcement in the pharmaceutical industry and work with other ministerial departments in the country to ensure the supply...To view the full article, register now.
Already a subscriber? Click here to view full article